Non-Alcoholic Fatty Liver Disease (NAFLD) Pipeline – Insights Into the Current Therapies, Emerging Drugs, & Treatment Outlook | Key Companies – Madrigal Pharma, Cirius Therapeutics, and Novo Nordisk